Ocular Therapeutix shares fall after Q3 earnings miss

This article was originally published here

Ocular Therapeutix logoShares in Ocular Therapeutix (NSDQ:OCUL) fell today after the company missed EPS estimates on Wall Street with its third-quarter financial results.

The Bedford, Mass.-based company posted a net loss of -$15 million on sales of $498,000 for the 3 months ended Sept. 30. Sales for the quarter were down -5% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Ocular Therapeutix shares fall after Q3 earnings miss appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply